Alabama Digestive Disorders Center, P.C.
Huntsville, Alabama, United States
Gastroenterologist in Huntsville, Alabama
4601 Whitesburg Dr UNIT 101, Huntsville, AL 35802
About Alabama Digestive Disorders Center, P.C.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Alabama Digestive Disorders Center, P.C.
During the past decade, Alabama Digestive Disorders Center, P.C. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Lymph Node Removal in Treating Patients With Stage I or Stage II Non-small Cell Lung Cancer
1999-07-01
2011-01-01
Completed
1,023
Combination Chemotherapy With or Without Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
1999-05-01
2017-07-19
Completed
475
Comparison of Two Combination Chemotherapy Regimens in Treating Patients With Stage III or Stage IV Hodgkin's Lymphoma
2002-08-01
Completed
552
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
2003-11-03
2025-12-01
Active, not recruiting
2,672
S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
2003-10-01
2016-09-01
Completed
257
Study of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer
2005-05-01
Completed
520
Safety and Efficacy of Avonex in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
2004-02-01
2006-02-01
Completed
67
Rituximab in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Follicular Non-Hodgkin's Lymphoma
2004-09-01
2022-05-01
Unknown status
600
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Alabama Digestive Disorders Center, P.C.
According to Clinical.Site data, the most researched conditions in "Alabama Digestive Disorders Center, P.C." are
"Adenomatous Polyps" (1 trials), "CRC Screening" (1 trials), "Inflammatory Bowel Disease" (1 trials) and "Small Bowel Disease" (1 trials). Many other conditions were trialed in "Alabama Digestive Disorders Center, P.C." in a lesser frequency.
Clinical Trials Intervention Types at Alabama Digestive Disorders Center, P.C.
Most popular intervention types in "Alabama Digestive Disorders Center, P.C." are "Device" (2 trials), "Procedure" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Colonoscopy" (2 trials), "0.5 mg calcitriol (1a -25-dihydroxycholecalciferol)" (1 trials), "75 mg acetylsalicylic acid (ASA) + 1250 mg calcium carbonate (CaCO3)" (1 trials), "PillCam® COLON 2 procedure" (1 trials) and "PillCam® Express Capsule Endoscopy Delivery System" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Alabama Digestive Disorders Center, P.C.
The vast majority of trials in "Alabama Digestive Disorders Center, P.C." are
3 trials for "All" genders.
Clinical Trials Status at Alabama Digestive Disorders Center, P.C.
Currently, there are NaN active trials in "Alabama Digestive Disorders Center, P.C.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Alabama Digestive Disorders Center, P.C.,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Alabama Digestive Disorders Center, P.C., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".